title: Clinical outcome of patients with acute promyelocytic leukemia and FLT3 mutations.
authors.forename: Harshabad
authors.initials: H
authors.lastname: Singh
authors.forename: Lillian
authors.initials: L
authors.lastname: Werner
authors.forename: Daniel
authors.initials: D
authors.lastname: Deangelo
authors.forename: Karen
authors.initials: K
authors.lastname: Ballen
authors.forename: Philip
authors.initials: P
authors.lastname: Amrein
authors.forename: Martha
authors.initials: M
authors.lastname: Wadleigh
authors.forename: Donna
authors.initials: D
authors.lastname: Neuberg
authors.forename: Edward
authors.initials: E
authors.lastname: Fox
authors.forename: Richard
authors.initials: R
authors.lastname: Stone
authors.forename: Eyal
authors.initials: E
authors.lastname: Attar
mesh_terms: D000328:Adult; D018572:Disease-Free Survival; D005260:Female; D005340:Fibrinogen / Q000032:analysis; D006801:Humans; D055029:Inverted Repeat Sequences; D015473:Leukemia, Promyelocytic, Acute / Q000235:genetics* / Q000401:mortality; D008297:Male; D009154:Mutation; D012306:Risk; D015996:Survival Rate; D016896:Treatment Outcome; D055815:Young Adult; D051941:fms-Like Tyrosine Kinase 3 / Q000235:genetics*
chemical_list: D005340:Fibrinogen; D051941:fms-Like Tyrosine Kinase 3